Related Experiment Video
Updated: Jan 7, 2026
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Antiphospholipid antibodies induce endothelial procoagulant activity and release of extracellular vesicles
Daniel Álvarez1,2,3, Hephzibah E Winter2, Udo R Markert2
1Grupo Reproducción, Departamento Microbiología y Parasitología, Facultad de Medicina, Universidad de Antioquia UdeA, Medellín, Colombia.
Introduction:
Antiphospholipid antibodies (aPLs) can promote thrombosis in vivo, but evidence from both animal models and clinical data suggests that they act as a 'first hit' and may require a 'second hit', typically an inflammatory stimulus, to induce thrombus formation. This study aimed to investigate whether polyclonal aPLs alone can induce effects in human endothelial cells that are sufficient to trigger ex vivo clot formation and to induce the release of endothelial extracellular vesicles (EVs) carrying an altered cargo.
Methods:
Human umbilical vein endothelial cells (HUVECs) were stimulated with IgG from patients with vascular and obstetric APS (IgG APS) or IgG purified from the serum of healthy women with proven gestational success (IgG healthy control -HC-). IgG binding to HUVECs, expression of tissue factor, and the procoagulant activity of the endothelial surface were evaluated. EVs were isolated from the supernatants and characterized by nanoparticle tracking analysis, cryo-transmission electron microscopy, flow cytometry, and Western blotting.
Results:
Compared to IgG HC, IgG APS showed increased binding to the endothelial surface upon prior and concomitant stimulus with LPS (HC 10.92; APS 81.61 mean fluorescence intensity -MFI-, p < 0.01). This enhanced binding capacity of IgG APS to HUVECs was preserved even in the absence of LPS (HC 12.23; APS 84.26 MFI, p < 0.05). Additionally, IgG APS enhanced the platelet-rich plasma-dependent procoagulant activity of the endothelial surface (HC 0.031; APS 0.098 clot density; p < 0.05), and the release of large EVs (HC 7.3 x 108; APS 1.1 x 109 particles; p < 0.05). These lEVs were frequently opsonized by IgG (lEVC 28.5; lEVAPS 40.6%, p < 0.001).
Conclusion:
Our findings suggest that IgG APS can trigger second hit-independent procoagulant mechanisms in HUVECs and induce the release of lEVs that subsequently display surface-bound IgG, highlighting a potential role for endothelial EVs in APS pathophysiology.
More Related Videos
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
01:30Venous Thrombosis I: Introduction
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:16Clot Retraction and Fibrinolysis